Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.
Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal
Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1730 in its research report dated June 01, 2026.
Buy Rubicon Research; target of Rs 1160: Motilal Oswal
Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 1160 in its research report dated May 30, 2026.
Neutral ALKEM Laboratories; target of Rs 5840: Motilal Oswal
Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5840 in its research report dated May 28, 2026.
SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.
Neutral Lupin; target of Rs 2520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2520 in its research report dated May 10, 2026.
Blue Jet Healthcare up 10% as net profit rises 60% sequentially in Q4, firm announces Rs 1,000-cr fund raise
The board has approved a proposal to raise up to Rs 1,000 crore through qualified institutional placement.
Max Healthcare shares fall up to 7% as Q4 results miss estimates
Analysts at domestic brokerage Motilal Oswal Financial Services said the earnings miss was due to a higher tax rate .
Neutral Zydus LifeSciences; target of Rs 1080: Motilal Oswal
Motilal Oswal recommended Neutral rating on Zydus LifeSciences with a target price of Rs 1080 in its research report dated May 20, 2026.
Stellar Wealth Partners India Fund acquires 0.87% stake in Sakar Healthcare, Zerodha Broking buys Rs 93 crore worth of Nazara Tech shares
Shares of Sakar Healthcare Limited may have reacted positively to the bulk deal, soaring 16.16 percent to end at a record closing high of Rs 696.7 amid strong volumes on the National Stock Exchange. Strong buying interest was also seen in Nazara Technologies Limited as its shares surged 12.76 percent to Rs 299.95.
Trade Spotlight: How should you trade Indus Towers, NMDC, Max Healthcare, BSE, KEI Industries, and others on May 15?
The market needs to reclaim and sustain above short-term moving average levels for a further uptrend. Below are some short-term trading ideas to consider.
Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal
Motilal Oswal recommended is bullish on Niva Bupa Health Insurance recommended buy rating on the stock with a target price of Rs 100 in its research report dated Jun 19, 2026.